12:16 PM EDT, 09/08/2025 (MT Newswires) -- The European stock markets closed mostly higher in Monday trading as the Stoxx Europe 600 rose 0.60%, Germany's DAX increased 0.96%, the FTSE gained 0.14%, France's CAC advanced 0.78%, and the Swiss Market Index was down 0.47%.

In Germany, price-adjusted production in the manufacturing sector rose by a seasonally and calendar-adjusted 1.3% in July from June, according to preliminary data from the Federal Statistical Office. Analysts expected a 1.1% increase, according to Bloomberg.

And in corporate news, German biotech firm BioNTech and Pfizer said Monday that preliminary data from a phase 3 study of their LP.8.1-adapted COVID-19 vaccine, Comirnaty, showed a robust immune response. Results showed LP.8.1-neutralizing antibody titers increased at least four-fold 14 days after vaccination in both age groups.

BioNTech shares fell more than 8% in Frankfurt.

Shares of Edenred fell 3.4% in Paris after the Turkish Competition Authority opened an investigation into whether the company violated competition laws in Turkey.

AstraZeneca said Sunday that results from a phase 3 trial of Tagrisso plus pemetrexed and platinum-based chemotherapy showed statistically significant and clinically meaningful improvement in the key secondary endpoint of overall survival compared with Tagrisso alone in patients with non-small cell lung cancer.

The pharmaceutical company's shares closed 1% lower in London.